Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
暂无分享,去创建一个
Stephen Wilson | Deborah Theodoros | Trevor Russell | Richard Wootton | R. Wootton | E. Ward | D. Theodoros | T. Russell | S. Wilson | Gabriella Constantinescu | Gabriella Constantinescu | Elizabeth Ward
[1] N. Schiavetti,et al. Construct validity of direct magnitude estimation and interval scaling of speech intelligibility: evidence from a study of the hearing impaired. , 1981, Journal of speech and hearing research.
[2] B. Murdoch,et al. Changes in Maximum Capacity Tongue Function following the Lee Silverman Voice Treatment Program , 2000 .
[3] A. Aronson,et al. Motor Speech Disorders , 2014 .
[4] L. Ramig,et al. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. , 2004, Seminars in speech and language.
[5] L. Ramig,et al. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. , 1995, Journal of speech and hearing research.
[6] L. Ramig,et al. Intentional changes in sound pressure level and rate: their impact on measures of respiration, phonation, and articulation. , 1998, Journal of speech, language, and hearing research : JSLHR.
[7] J. Fleiss. Statistical methods for rates and proportions , 1974 .
[8] S. Countryman,et al. Comparison of two forms of intensive speech treatment for Parkinson disease. , 1995, Journal of speech and hearing research.
[9] Jennifer L. Spielman,et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. , 2007, Journal of speech, language, and hearing research : JSLHR.
[10] T. Whitehill,et al. Direct magnitude estimation and interval scaling of hypernasality. , 2002, Journal of speech, language, and hearing research : JSLHR.
[11] Gary Weismer,et al. Direct magnitude estimates of speech intelligibility in dysarthria: effects of a chosen standard. , 2002, Journal of speech, language, and hearing research : JSLHR.
[12] S. Countryman,et al. Intensive speech treatment for patients with Parkinson's disease , 1996, Neurology.
[13] Douglas G Altman,et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.
[14] Stephen Wilson,et al. Treating the speech disorder in Parkinson's disease online , 2006 .
[15] R. Huebner,et al. Videophone-delivered voice therapy: a comparative analysis of outcomes to traditional delivery for adults with Parkinson's disease. , 2008, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[16] Lorraine O. Ramig,et al. The Lee Silverman Voice Treatment: A Practical Guide to Treating the Voice and Speech Disorders in Parkinson’s Disease , 1995 .
[17] S. Sapir,et al. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. , 2001, Journal of voice : official journal of the Voice Foundation.
[18] Lorraine O. Ramig,et al. Vocal Sound Pressure Level and Self-Perception of Speech and Voice in Men and Women With Idiopathic Parkinson Disease , 1997 .
[19] A. Goberman,et al. Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. , 2005, Journal of communication disorders.
[20] T. Pring,et al. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. , 2009, International journal of language & communication disorders.
[21] L. Raming,et al. Voice treatment for patients with Parkinson desease: Development of an approach and preliminary efficacy data , 1994 .
[22] Lorraine O. Ramig,et al. Speech Loudness and Quality 12 Months after Intensive Voice Treatment (LSVT®) for Parkinson’s Disease: A Comparison with an Alternative Speech Treatment , 2002, Folia Phoniatrica et Logopaedica.
[23] S. Countryman,et al. Intensive voice treatment (LSVT®) for patients with Parkinson's disease: a 2 year follow up , 2001 .
[24] J A Lewis,et al. Trials to assess equivalence: the importance of rigorous methods , 1996, BMJ.
[25] J. Dartigues,et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[26] A. Aronson,et al. Clusters of deviant speech dimensions in the dysarthrias. , 1969, Journal of speech and hearing research.
[27] Jeri Logemann,et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study , 2002, INTERSPEECH.
[28] S. Countryman,et al. Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls , 2001, Movement disorders : official journal of the Movement Disorder Society.
[29] S. S. Stevens,et al. Psychophysics: Introduction to Its Perceptual, Neural and Social Prospects , 1975 .
[30] G. Fairbanks. Voice and articulation drillbook , 1960 .
[31] M. Hoehn,et al. Parkinsonism , 1967, Neurology.